Is Axogen, Inc. (AXGN) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 4.6% / 30% | 2.8% / 30% | 1.8% / 30% | 0.07% / 5% | ✓ HALAL |
| DJIM | 4.6% / 33% | 2.8% / 33% | 1.8% / 33% | 0.07% / 5% | ✓ HALAL |
| MSCI | 30.5% / 33% | 18.7% / 33% | 11.8% / 33% | 0.07% / 5% | ✓ HALAL |
| S&P | 4.6% / 33% | 2.8% / 33% | 1.8% / 33% | 0.07% / 5% | ✓ HALAL |
| FTSE | 30.5% / 33% | 18.7% / 33% | 11.8% / 50% | 0.07% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 74.3% | |
| Operating Margin | -16.3% | |
| Net Margin | -7.0% | |
| Return on Equity (ROE) | -13.5% | |
| Return on Assets (ROA) | -2.3% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $812,000 |
| Free Cash Flow | -$5M |
| Total Debt | $68M |
| Debt-to-Equity | 55.5 |
| Current Ratio | 5.1 |
| Total Assets | $222M |
Price & Trading
| Last Close | $32.25 |
| 50-Day MA | $32.64 |
| 200-Day MA | $22.76 |
| Avg Volume | 966K |
| Beta | 1.0 |
|
52-Week Range
$9.22
| |
About Axogen, Inc. (AXGN)
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. It also provides Axoguard HA+ Nerve Protector, a surgical implant for non-constricting protection of the peripheral nerves; Axoguard Nerve Cap, a porcine submucosa ECM product; Avive+ Soft Tissue Matrix, a multi-layer amniotic membrane allograft; and Avance Method, a technique to process Avance Nerve Graft from donated human peripheral nerve tissue. In addition, the company offers peripheral nerve tissue recovery and acquisition, and testing, as well as donor medical review and release, debridement and other processing steps, packaging, and sterilization. It provides its products to hospitals, surgery centers and military hospitals, calling on surgeons, including plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and certain oral and maxillofacial surgeons through independent in-country distributors. The company is headquartered in Alachua, Florida.
Purification Calculator
As a halal stock with 0.07% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Axogen, Inc. (AXGN) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Axogen, Inc. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Axogen, Inc.'s debt ratio?
Axogen, Inc.'s debt ratio is 4.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 30.5%.
Does Axogen, Inc. require dividend purification?
Yes, Axogen, Inc. has an impermissible income ratio of 0.07%, which means 0.07% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are Axogen, Inc.'s key financial metrics?
Axogen, Inc. has a market capitalization of $1.6B, and revenue of $225M. The company maintains a gross margin of 74.3% and a net margin of -7.0%. Return on equity stands at -13.5%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.